Genentech's Herceptin gets approval in U.S.
Submitted by ipsita on Sun, 1997-12-28 10:30
Genentech Inc. won unusually swift U.S. Food and Drug Administration approval to market its breast cancer drug, Herceptin, the first rifleshot attack on underlying causes of the disease. The drug,
Main Topic:
Mark Content Private(Internal):
Clipping Type:
DNB
External URL:
Main Type:
dte-DNB
Publication Date:
28/12/1997